Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Vita Coco Company Inc (COCO) vs Zoetis Inc (ZTS) Price & Performance

The Vita Coco Company IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

The Vita Coco Company Inc vs Zoetis Inc — how do they compare? The Vita Coco Company Inc trades at $74.45 (market cap $4.23B), while Zoetis Inc trades at $74.75 (market cap $31.05B). The key difference: Zoetis Inc is far larger — about 7.3× The Vita Coco Company Inc's market cap, and Zoetis Inc pays a 2.86% dividend while The Vita Coco Company Inc pays none. Which is the better fit depends on your goals.

COCOZTS
Market Cap
$4.23B$31.05B
Sector
TechnologyHealth
52-Week High
$84.02$156.76
52-Week Low
$32.30$71.91
Enterprise Value
$4.04B$38.35B
Dividend Yield
2.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Vita Coco Company Inc

COCO trades at $74.635, up 4.53% today, with a bullish technical signal and strong earnings momentum after beating Q1 2026 EPS estimates. The company reported 37% YoY revenue growth in Q1 2026, with management raising full-year guidance. Analysts maintain a $78.00 consensus price target, with 60% recommending Buy. Key support lies at $72, with resistance at $76.

Outlook remains positive driven by international expansion and dominant market position, but elevated valuation multiples pose risks. Upside depends on sustained execution against raised guidance, while any earnings miss or margin pressure could trigger volatility. The stock offers growth exposure but requires monitoring of competitive and consumer spending trends.

Zoetis Inc

Zoetis (ZTS) trades at $75.39, down 0.22% with bearish technical signals and mixed sentiment. The company maintains strong fundamentals with $9.47B revenue, 28.03% net margin, and robust profitability metrics (ROE 67.75%, ROA 18.27%). Recent Q1 2026 earnings missed expectations, while multiple law firms have filed class action lawsuits alleging securities violations between January 2025 and May 2026.

Despite strong financials and analyst consensus price target of $101.43 (34.5% upside), ZTS faces significant legal risks and technical weakness. The stock presents a value opportunity for long-term investors willing to navigate near-term volatility, though the class action lawsuits create substantial uncertainty for shareholder value.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About The Vita Coco Company Inc

The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.

Read more on COCO

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS